Sale of 01dB-Metravib
Press Release
AREVA / REACTORS AND SERVICES
December 14, 2011
AREVA announces today the closing of the sale of 01dB-Metravib, an AREVA TA subsidiary, to the management team of 01dB-Metravib in partnership with the Lyon-based investment fund EVOLEM.
Based in Limonest near Lyon (France), 01dB-Metravib is an international company specializing in acoustics and vibration with a workforce totaling 320 people and sales revenues of about €40 M.
After a competitive disposal process involving numerous French and foreign investors, the project proposed by the managers and EVOLEM was the most suitable to develop the activities of 01dB-Metravib, while fulfilling AREVA expectations and maintaining employment on all the company’s sites.
Contacts
- AREVA press office:
Patricia Marie / Pauline Briand / Maxime Michaut
Tel: +33 1 34 96 12 15 - Fax: +33 1 34 96 16 54
email: press@areva.com - AREVA Investors Relations:
Marie de Scorbiac / Philippine du Repaire
T: +33 (0) 1 34 96 11 51
email: marie.descorbiac@areva.com
email: philippine.durepaire@areva.com

The Path of Greatest Certainty: brochure
EPR™ Safety Robustness
Uranium mines: more efficient or more sustainable?
EPR™: discover the advanced reactor
"Flamanville 3 Project" (EDF)
The Chalon Saint-Marcel plant guided tour
After Fukushima, should we question the use of nuclear energy?
Is nuclear power a sustainable energy source?
